Dansplaining Dan's Current Projects
I'm always getting ideas for storylines! Of course, most of the time, an idea dies at the inception stage, but once in a while, the inspiration grows into a full-fledged plot for a novel. Here is the latest work I'm doing on the next Churachian novel.
Dansplaining KAIROS For release in mid-to-late 2022
Dan Churach's "The Ancestors Trilogy": EIGHT (2020), SOLASTALGIA (2021) and KAIROS (2022).
KAIROS is the third story in "The Ancestors Trilogy" and derives the title from the Greek term kairos. It picks up from the end of SOLASTALGIA and continues on with familiar characters as well as some new ones.
Why the title KAIROS? Kairos (καιρός) is an Ancient Greek word meaning the right, critical, or opportune moment. The ancient Greeks had two words for time: chronos (χρόνος) and kairos. The former refers to chronological or sequential time, while the latter signifies a proper or opportune time for action. I am about two-thirds of the way through the first draft of KAIROS as I write this, the end of April 2022. With any luck, the novel will be published by midyear.
Kairos, dear reader... it is time...
Dansplaining CLOUDS For release after KAIROS
I'm already a quarter-to-a-third of the way into writing this novel, but was distracted by SOLASTALGIA and wrote that story. I then picked up writing CLOUDS the last few months of 2021 before I became distracted with inspirations pushing me to write KAIROS (see above). That said, I will get back to CLOUDS in a few months. CLOUDS is only a working title, but the way the story is unfolding, it may be the final title of my next technothriller. I can at least give you some insight as to what I'm working on.
GenoBotics is a new start-up company developed by a couple of Western Australia researchers attempting to use the laws of physics integrated with biomolecular research to develop robotic devices that are as small as molecules. These nanobots can be used medically to deliver drugs to precisely the right place within an individual’s body to help remedy disease. The best example of this technique is in the early stages of development today and will be used to allow oncologists to better treat cancer patients.
Caution: NOT a real nanobot!
Many modern pharmaceuticals intended to fight cancer are designed to interfere inside the targeted malignant cells and cause harm to their DNA. Naturally, the trick is to confine their therapeutic behaviour of the chemo drugs specifically to only the diseased cells making up the tumour. Enter nanorobotics and the guided attack on only unhealthy cells. Enough of the science for now.
GenoBotics shows much promise, but as often is the case with Australian research, the lack of seed money drives GenoBotics into a merger with Gunn Capital, a large California-based company keen on backing this cutting-edge research.
That's where CLOUDS is in May 2022 - to be continued after I put KAIROS out to the publishers.…
Nanobots at work in a bloodstream... Again, don't take the image too seriously, but it gives at least some idea of what GenoBotics is all about - manipulating VERY small bits within the human body..